NONO mitigates transcription-replication conflicts during replication stress by restraining BRD4-dependent transcription elongation.

NONO prevents transcription-replication conflicts during replication stress by restraining BRD4-dependent transcription elongation, reducing genomic instability.

• Why it matters: Genomic instability from transcription-replication conflicts contributes to tumor development and affects treatment responses, but the mechanisms controlling these conflicts under stress are not well understood.
• What they did: The study identified NONO as a regulator that, upon replication stress-induced acetylation at K243, enhances BRD4 binding and forms condensates on single-stranded DNA to regulate RNAP2 elongation, with experiments involving loss of NONO and conditions like ATR inhibition or BRCA2 deficiency.
• The result: Loss of NONO leads to increased elongating RNAP2 at termination regions, promoting TRCs and genomic instability, especially under conditions that increase origin firing, suggesting NONO as a potential target in replication stress-related cancers.